Rhythm Pharmaceuticals Stock (NASDAQ: RYTM) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 599.967K |
Day Range | - - - |
52 Wk Range | 15.500 - 52.570 |
Market Cap | $2.406B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 25.99% |
Days to Cover | 16.16 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Rhythm Pharmaceuticals (NASDAQ: RYTM) through any online brokerage.
Other companies in Rhythm Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX), TG Therapeutics (NASDAQ:TGTX) and PTC Therapeutics (NASDAQ:PTCT).
The latest price target for Rhythm Pharmaceuticals (NASDAQ: RYTM) was reported by Wells Fargo on Thursday, April 18, 2024. The analyst firm set a price target for 52.00 expecting RYTM to rise to within 12 months (a possible 30.00% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Rhythm Pharmaceuticals (NASDAQ: RYTM) is $40 last updated April 23, 2024 at 4:05 PM EDT.
There are no upcoming dividends for Rhythm Pharmaceuticals.
Rhythm Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Rhythm Pharmaceuticals.
Rhythm Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.